𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

✍ Scribed by Richard R. Love; Richard B. Mazess; Douglass C. Tormey; Howard S. Barden; Polly A. Newcomb; V. Craig Jordan

Publisher
Springer US
Year
1988
Tongue
English
Weight
398 KB
Volume
12
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Genetic polymorphisms of CYP2D6*10 and C
Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen
✍ Matthew Goetz; Vera Suman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

The study by Okishiro et al 1 concludes that the cytochrome P450 (CYP) genotype CYP2D6\*10/\*10 is unlikely to have a clinically significant impact on prognosis in women with breast cancer who receive adjuvant tamoxifen. However, several aspects of the study by Okishiro et al call their conclusions